First Lung Disease Drug? Insmed’s New Breath of Billion$
Insmed just scored FDA clearance for what looks like the first ever treatment for a chronic lung disease, opening a potential multibillion-dollar jackpot. The biotech proudly announced it 'received FDA clearance' for this groundbreaking product, finally giving lungs everywhere some VIP access. This means instead of just gasping for air like your phone in 1% battery, patients might actually get relief. Investors must be breathing a sigh of relief too—hopefully, their profits don’t end up as breathless as untreated lungs.
Share the Story
(1 of 3)Insmed got FDA clearance for the first chronic lung disease treatment. Finally, a drug that makes lungs less like that one embarrassing uncle at parties — totally unmanageable and desperate for attention.
Insmed's lung drug just got FDA clearance. Soon lungs everywhere will stop ghosting oxygen like it’s their ex on social media.
In a world where lungs were ignored like expired memes, Insmed just dropped the OG treatment making waves and profits alike.
Source: Statnews | Published: 8/12/2025 | Author: Elaine Chen
More Articles in Health
Army Launches 9-1-1 Hotline Because Soldiers Really Love Calling IT
Microsoft Finally Lets Windows 11 Fans Stop Pretending to Use ViVeTool
Epstein Survivors Declare 'Done' While Melania Passes the Buck Faster Than a Baton
Telehealth Startup Outsources Doctors to AI and Angolan Phone Lines
Widow Turns Frozen Sperm Time Capsule Into Baby After 10-Year Hiatus
OpenAI CEO Temporarily Downgrades from AI Overlord to Human POTS Patient
Woman Quits Job at 38 to Audit Diaper Changing as Full-Time Gig
Utah Lets Robot Shrink Prescribe Meds, Because What Could Go Wrong?
